Inhaled Nanomedicines for Lung Diseases and Injuries: Pharmacological Advances and Clinical Translation.
This review examines how disease biology informs pulmonary delivery design across pulmonary fibrosis, lung cancer, chronic obstructive pulmonary disease, pulmonary infections, and acute lung injury/acute respiratory distress syndrome and outlines anatomical and biological barriers.
Kajal Kamra, Sonal Gaur, Jaswinder Singh
· MedComm · 0 citations